Insider Trading May 27, 2026 05:42 PM

Itron's Insider Activity and Recent Financial Performance Under Scrutiny

Analysis of SVP stock sale juxtaposed with Q1 earnings beat and adjusted analyst outlook.

By Hana Yamamoto ITRI

The article details a recent insider transaction by an Itron executive, John F. Marcolini, alongside the company's strong first-quarter financial results for 2026. While Itron surpassed expectations in revenue and EPS, the stock faced pre-market concerns, and analysts also adjusted their price targets.

Itron's Insider Activity and Recent Financial Performance Under Scrutiny
ITRI

Key Points

  • Insider transactions from senior executives like John F. Marcolini provide insights into internal sentiment regarding company valuation and future performance.
  • Itron reported robust financial outcomes for the first quarter of 2026, achieving earnings per share (EPS) of $1.49 and revenue of $587 million, both exceeding market forecasts.
  • Despite positive operational results, the stock has faced mixed signals, including pre-market trading concerns and a recent downward adjustment in analyst price targets.

Insider activity at technology firms often provides a critical lens through which investors view internal confidence and management's perception of corporate valuation. In a recent development concerning Itron, Inc. (NASDAQ:ITRI), John F. Marcolini, Senior Vice President of Networked Solutions, reported the disposal of company common stock on May 26, 2026.

Specifically, Mr. Marcolini sold 322 shares of the company's common stock at a price of $84.3667 per share. This transaction resulted in a total divestment value of $27,166. The article clarifies that this sale was primarily executed to cover tax withholding obligations associated with the vesting of a restricted stock unit award. Following the completion of this sale, John F. Marcolini's direct holdings of Itron common stock were noted as 24,689 shares.


Despite the recent insider transaction, other financial indicators for Itron suggest underlying strength and potential value. The $3.78 billion company currently trades with a Price-to-Earnings (P/E) ratio of 13.6. According to data provided by InvestingPro, this P/E ratio is suggested to be relatively low when compared against the anticipated near-term earnings growth. Furthermore, the platform's Fair Value analysis implies that the stock may appear undervalued. This assessment is supported by the Financial Health score, which rates Itron as having a

Risks

  • The near-term revenue growth trajectory is described as more subdued due to factors related to complex projects and temporary regulatory dynamics.
  • Pre-market trading performance reflected investor concerns despite the company's strong reported financial results for Q1 2026.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026